Date of Presentation
5-2-2019 12:00 AM
College
School of Osteopathic Medicine
Poster Abstract
In 2012 The United States Preventive Services Task Force (USPSTF) recommended against prostate cancer (Pca) screening. The purpose of our study is to assess the effects of the USPSTF grade D recommendation for PSA based screening on new PCa diagnoses within a large-community based private practice setting. We completed a retrospective chart review of men with an elevated PSA seen in our clinic between May 2009–May 2015 who had undergone a prostate biopsy and were diagnosed with PCa. We observed that following the 2012 USPSTF recommendations, there was a significant increase in patients with clinically significant prostate cancer GG ≥ 2, with the majority being 55-65 years of age. In addition we observed a decrease in the diagnosis of very low and low risk PCa with an increased incidence of intermediate and high risk PCa.
Keywords
prostate cancer, disease risk, USPSTF, preventative screening
Disciplines
Community Health and Preventive Medicine | Male Urogenital Diseases | Medicine and Health Sciences | Neoplasms | Urology
Document Type
Poster
Included in
Community Health and Preventive Medicine Commons, Male Urogenital Diseases Commons, Neoplasms Commons, Urology Commons
Referral Patterns, Procedures, and Outcomes of a Large Community- Based Urology Group: a Retrospective Chart Review
In 2012 The United States Preventive Services Task Force (USPSTF) recommended against prostate cancer (Pca) screening. The purpose of our study is to assess the effects of the USPSTF grade D recommendation for PSA based screening on new PCa diagnoses within a large-community based private practice setting. We completed a retrospective chart review of men with an elevated PSA seen in our clinic between May 2009–May 2015 who had undergone a prostate biopsy and were diagnosed with PCa. We observed that following the 2012 USPSTF recommendations, there was a significant increase in patients with clinically significant prostate cancer GG ≥ 2, with the majority being 55-65 years of age. In addition we observed a decrease in the diagnosis of very low and low risk PCa with an increased incidence of intermediate and high risk PCa.